Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $229,342 - $268,645
-3,876 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $6,624 - $7,213
-107 Reduced 2.69%
3,876 $259,000
Q1 2021

May 17, 2021

BUY
$59.34 - $66.74 $30,026 - $33,770
506 Added 14.55%
3,983 $253,000
Q4 2020

May 14, 2021

BUY
$57.74 - $65.43 $200,761 - $227,500
3,477 New
3,477 $216,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Sage Guard Financial Group, LLC Portfolio

Follow Sage Guard Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sage Guard Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sage Guard Financial Group, LLC with notifications on news.